• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒酶的药物调控及其临床潜力。

Pharmaceutical regulation of telomerase and its clinical potential.

机构信息

Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

出版信息

J Cell Mol Med. 2012 Jan;16(1):1-7. doi: 10.1111/j.1582-4934.2011.01460.x.

DOI:10.1111/j.1582-4934.2011.01460.x
PMID:21973217
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3251731/
Abstract

Telomeres serve the dual function of protecting chromosomes from genomic instability as well as protecting the ends of chromosomes from DNA damage machinery. The enzyme responsible for telomere maintenance is telomerase, an enzyme capable of reverse transcription. Telomerase activity is typically limited to specific cell types. However, telomerase activation in somatic cells serves as a key step toward cell immortalization and cancer. Targeting telomerase serves as a potential cancer treatment with significant therapeutic benefits. Beyond targeting cancers by inhibiting telomerase, manipulating the regulation of telomerase may also provide therapeutic benefit to other ailments, such as those related to aging. This review will introduce human telomeres and telomerase and discuss pharmacological regulation of telomerase, including telomerase inhibitors and activators, and their use in human diseases.

摘要

端粒具有双重功能,既能保护染色体免受基因组不稳定性的影响,又能保护染色体末端免受 DNA 损伤机制的影响。负责端粒维持的酶是端粒酶,一种能够进行逆转录的酶。端粒酶活性通常仅限于特定的细胞类型。然而,体细胞中端粒酶的激活是细胞永生化和癌症的关键步骤。靶向端粒酶是一种具有显著治疗益处的潜在癌症治疗方法。除了通过抑制端粒酶来靶向癌症外,调控端粒酶的调节也可能为其他疾病(如与衰老相关的疾病)提供治疗益处。本综述将介绍人类端粒和端粒酶,并讨论端粒酶的药理学调控,包括端粒酶抑制剂和激活剂及其在人类疾病中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5739/3823088/ba9944bbbf44/jcmm0016-0001-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5739/3823088/ba9944bbbf44/jcmm0016-0001-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5739/3823088/ba9944bbbf44/jcmm0016-0001-f1.jpg

相似文献

1
Pharmaceutical regulation of telomerase and its clinical potential.端粒酶的药物调控及其临床潜力。
J Cell Mol Med. 2012 Jan;16(1):1-7. doi: 10.1111/j.1582-4934.2011.01460.x.
2
Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.影响端粒酶活性的药理学干预策略:治疗癌症和退行性疾病的未来前景
Biochimie. 2008 Jan;90(1):156-72. doi: 10.1016/j.biochi.2007.09.002. Epub 2007 Sep 11.
3
Targeting telomeres and telomerase.靶向端粒与端粒酶。
Biochimie. 2008 Jan;90(1):131-55. doi: 10.1016/j.biochi.2007.07.011. Epub 2007 Jul 24.
4
Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.端粒和端粒酶在癌症中的作用以及端粒酶靶向治疗的进展。
Genome Med. 2016 Jun 20;8(1):69. doi: 10.1186/s13073-016-0324-x.
5
Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.敌友难辨?端粒酶作为癌症和心血管疾病的药物靶点
Pharmacol Res. 2016 Sep;111:422-433. doi: 10.1016/j.phrs.2016.07.003. Epub 2016 Jul 6.
6
Telomeres and telomerase as targets for cancer therapy.端粒与端粒酶作为癌症治疗的靶点。
Cell Mol Life Sci. 2007 Apr;64(7-8):906-21. doi: 10.1007/s00018-007-6481-8.
7
Telomere and telomerase in oncology.肿瘤学中的端粒与端粒酶
Cell Res. 2002 Mar;12(1):1-7. doi: 10.1038/sj.cr.7290104.
8
Telomeres and telomere dynamics: relevance to cancers of the GI tract.端粒和端粒动力学:与胃肠道癌症的相关性。
Expert Rev Gastroenterol Hepatol. 2013 Nov;7(8):733-48. doi: 10.1586/17474124.2013.848790.
9
Telomeres and telomerase: three decades of progress.端粒与端粒酶:三十年的进展。
Nat Rev Genet. 2019 May;20(5):299-309. doi: 10.1038/s41576-019-0099-1.
10
Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.端粒酶抑制剂和“T-寡核苷酸”作为癌症治疗药物:细胞毒性的不同分子机制
Anticancer Drugs. 2008 Apr;19(4):329-38. doi: 10.1097/CAD.0b013e3282f5d4c2.

引用本文的文献

1
Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate, complete and combinatory attack (TICCA).在癌症治疗中靶向端粒酶方面结合新旧概念:短暂、即时、完全和联合攻击(TICCA)。
Cancer Cell Int. 2023 Sep 7;23(1):197. doi: 10.1186/s12935-023-03041-2.
2
Tankyrase: a promising therapeutic target with pleiotropic action.端锚聚合酶:一种具有多效性作用的有前景的治疗靶点。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Dec;396(12):3363-3374. doi: 10.1007/s00210-023-02576-5. Epub 2023 Jun 20.
3
Potential Methods of Targeting Cellular Aging Hallmarks to Reverse Osteoarthritic Phenotype of Chondrocytes.

本文引用的文献

1
Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination.哺乳动物端粒的比较生物学:关于祖先状态的假说和端粒在寿命决定中的作用。
Aging Cell. 2011 Oct;10(5):761-8. doi: 10.1111/j.1474-9726.2011.00718.x. Epub 2011 Jun 1.
2
A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells.没食子酸表没食子儿茶素酯的新型前药:人乳腺癌细胞中不同的表观遗传端粒酶逆转录酶抑制作用。
Cancer Prev Res (Phila). 2011 Aug;4(8):1243-54. doi: 10.1158/1940-6207.CAPR-11-0009. Epub 2011 Mar 16.
3
hERG potassium channel gating is mediated by N- and C-terminal region interactions.
靶向细胞衰老特征以逆转软骨细胞骨关节炎表型的潜在方法。
Biology (Basel). 2022 Jun 30;11(7):996. doi: 10.3390/biology11070996.
4
Human Telomerase Reverse Transcriptase as a Therapeutic Target of Dihydroartemisinin for Esophageal Squamous Cancer.人端粒酶逆转录酶作为双氢青蒿素治疗食管鳞状细胞癌的靶点
Front Pharmacol. 2021 Oct 22;12:769787. doi: 10.3389/fphar.2021.769787. eCollection 2021.
5
Telomere length: how the length makes a difference.端粒长度:长短的差异。
Mol Biol Rep. 2020 Sep;47(9):7181-7188. doi: 10.1007/s11033-020-05551-y. Epub 2020 Sep 2.
6
The Link between Chronic Stress and Accelerated Aging.慢性压力与加速衰老之间的联系。
Biomedicines. 2020 Jul 7;8(7):198. doi: 10.3390/biomedicines8070198.
7
Telomerase Reverse Transcriptase Polymorphism rs2736100: A Balancing Act between Cancer and Non-Cancer Disease, a Meta-Analysis.端粒酶逆转录酶多态性rs2736100:癌症与非癌症疾病之间的平衡,一项荟萃分析
Front Med (Lausanne). 2018 Feb 27;5:41. doi: 10.3389/fmed.2018.00041. eCollection 2018.
8
Articular Cartilage Aging-Potential Regenerative Capacities of Cell Manipulation and Stem Cell Therapy.关节软骨老化-细胞操作和干细胞治疗的潜在再生能力。
Int J Mol Sci. 2018 Feb 22;19(2):623. doi: 10.3390/ijms19020623.
9
Ascorbic Acid Attenuates Senescence of Human Osteoarthritic Osteoblasts.抗坏血酸可减轻人骨性关节炎成骨细胞衰老。
Int J Mol Sci. 2017 Nov 24;18(12):2517. doi: 10.3390/ijms18122517.
10
Assessment Effects of Resveratrol on Human Telomerase Reverse Transcriptase Messenger Ribonucleic Acid Transcript in Human Glioblastoma.白藜芦醇对人胶质母细胞瘤中人类端粒酶逆转录酶信使核糖核酸转录本的评估作用
Adv Biomed Res. 2017 Jun 27;6:73. doi: 10.4103/2277-9175.209047. eCollection 2017.
hERG 钾通道门控是由 N 端和 C 端区域相互作用介导的。
J Gen Physiol. 2011 Mar;137(3):315-25. doi: 10.1085/jgp.201010582.
4
Medical genetics and epigenetics of telomerase.端粒酶的医学遗传学和表观遗传学。
J Cell Mol Med. 2011 Mar;15(3):457-67. doi: 10.1111/j.1582-4934.2011.01276.x.
5
Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies.端粒维持中的基因变异及其对组织更新能力和慢性疾病病理学的影响。
Curr Pharmacogenomics Person Med. 2010 Mar 1;8(1):7-24. doi: 10.2174/1875692111008010007.
6
Telomerase structure function.端粒酶结构与功能。
Curr Opin Struct Biol. 2011 Feb;21(1):92-100. doi: 10.1016/j.sbi.2010.11.005. Epub 2010 Dec 17.
7
The role of telomeres and telomerase in stem cell aging.端粒和端粒酶在干细胞衰老中的作用。
FEBS Lett. 2010 Sep 10;584(17):3826-30. doi: 10.1016/j.febslet.2010.07.042. Epub 2010 Aug 3.
8
Mechanisms and regulation of DNA end resection.DNA 末端切除的机制与调控。
EMBO J. 2010 Sep 1;29(17):2864-74. doi: 10.1038/emboj.2010.165. Epub 2010 Jul 20.
9
Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines.萝卜硫素导致人类乳腺癌细胞系中端粒酶逆转录酶表达的表观遗传抑制。
PLoS One. 2010 Jul 6;5(7):e11457. doi: 10.1371/journal.pone.0011457.
10
Telomeres and telomerase in normal and cancer stem cells.端粒和端粒酶在正常和肿瘤干细胞中的作用。
FEBS Lett. 2010 Sep 10;584(17):3819-25. doi: 10.1016/j.febslet.2010.05.026. Epub 2010 May 21.